艾昆纬-_中东与非洲医药商业季刊_第三十六版（英）-2025_28页_1mb

Overall pharmaceutical market performance in the Middle East and Africa region shows strong growth, with a total value of $36.82 billion in the latest quarter, experiencing an 11.96% increase driven primarily by retail channels and multinational companies. Retail sales continue to dominate with a 67.3% share, while hospital channels also showed positive growth. Key countries like Saudi Arabia and the UAE lead in sales, accounting for significant portions of the market, and growth is attributed to expanding local/regional firms and high-performing therapy areas such as Alimentary Tract treatments.

Forecast data indicates that the MEA pharmaceutical market is expected to reach $69.56 billion by 2029, emphasizing a steady compound annual growth rate. Therapy area analysis highlights Alimentary Tract as the fastest-growing category, impacting regional sales dynamics. Market trends include increased digital data coverage for enhanced insights into consumer and HCP engagement, with case studies showcasing successful brand strategies. Local companies are gaining ground, while MNCs maintain a larger market share, reflecting evolving competition.

Sales by country and channel demonstrate variations, with KSA leading both value and volume growth. Data suppliers and analytical tools provide granular insights for strategic decision-making. The report underscores the region's dynamic nature, highlighting both opportunities and risks in the pharmaceutical sector.